Therapy of chronic hepatitis C in people who inject drugs: focus on adherence

BACKGROUND: Intravenous drug use (IVDU) represents the major factor of HCV transmission, but the treatment uptake among people who inject drugs (PWID) remains low owing to a false presumption of low efficacy. The aim of our study was to assess treatment efficacy in PWID and factors determining adher...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankova, Sona, Jandova, Zuzana, Jinochova, Gabriela, Kreidlova, Miluse, Merta, Dusan, Sperl, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247095/
https://www.ncbi.nlm.nih.gov/pubmed/34193156
http://dx.doi.org/10.1186/s12954-021-00519-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247095/
https://www.ncbi.nlm.nih.gov/pubmed/34193156
http://dx.doi.org/10.1186/s12954-021-00519-y

Ejemplares similares